Details for New Drug Application (NDA): 022345
✉ Email this page to a colleague
The generic ingredient in POTIGA is ezogabine. Additional details are available on the ezogabine profile page.
Summary for 022345
Tradename: | POTIGA |
Applicant: | Glaxosmithkline |
Ingredient: | ezogabine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Jun 10, 2011 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jun 10, 2011 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Jun 10, 2011 | TE: | RLD: | Yes |
Complete Access Available with Subscription